Comparing molecular assessment of implantation biopsies with histologic and demographic risk assessment

American Journal of Transplantation

Volumn 13, Issue 2, 2013, Pages 415-426

  Kreepala, C ^a   Famulski, K S ^a,b   Chang, J ^a   Halloran, P F ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Delayed graft function; donation after brain death; gene expression; prediction

Indexed keywords

CREATININE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY DYSFUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION; RISK ASSESSMENT;

ADULT; AGE FACTORS; AGED; BIOPSY; BRAIN DEATH; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RENAL INSUFFICIENCY; RISK ASSESSMENT; RNA, MESSENGER; TISSUE DONORS;

EID: 84873092189     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12043     Document Type: Article

References (52)

1. Halloran PF, Hunsicker LG,. Delayed graft function: State of the art, November 10-11, 2000. Summit meeting, Scottsdale, Arizona, USA. Am J Transplant 2001; 1: 115-120.
2. Michael, Cecka J, Shoskes DA, Gjertson DW,. Clinical impact of delayed graft function for kidney transplantation. Transplant Rev 2001; 15: 57-67.
3. Einecke G, Sis B, Reeve J, et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9: 2520-2531.
4. Gaston RS, Cecka JM, Kasiske BL, et al. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplant 2010; 90: 68-74.
5. Mueller TF, Reeve J, Jhangri GS, et al. The transcriptome of the implant biopsy identifies donor kidneys at increased risk of delayed graft function. Am J Transplant 2008; 8: 78-85.
6. Melk A, Schmidt BMW, Braun H, et al. Effects of donor age and cell senescence on kidney allograft survival. Am J Transplant 2009; 9: 114-123.
7. Melk A, Schmidt BM, Vongwiwatana A, Rayner DC, Halloran PF,. Increased expression of senescence-associated cell cycle inhibitor p16INK4a in deteriorating renal transplants and diseased native kidney. Am J Transplant 2005; 5: 1375-1382.
8. Zou Y, Yoon S, Jung KJ, et al. Upregulation of aortic adhesion molecules during aging. J Gerontol A Biol Sci Med Sci 2006; 61: 232-244.
9. Charreau B,. Molecular regulation of endothelial cell activation: Novel mechanisms and emerging targets. Curr Opin Organ Transplant 2011; 16: 207-213.
10. The Organ Procurement and Transplantation Network (OPTN) Donors Recovered in the U.S. by Donor Type, Donors Recovered: January 1, 1988-January 31, 2012. 2012. Ref Type: Internet Communication
11. Rao PS, Schaubel DE, Guidinger MK, et al. A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplant 2009; 88: 231-236.
12. Schold JD, Kaplan B, Baliga RS, Meier-Kriesche HU,. The broad spectrum of quality in deceased donor kidneys. Am J Transplant 2005; 5 (4 Pt 1): 757-765.
13. Irish WD, Mccollum DA, et al. Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients. JASN 2003; 14: 2967-2974.
14. Irish WD, Ilsley JN, Schnitzler MA, Feng S, Brennan DC,. A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation. Am J Transplant 2010; 10: 2279-2286.
15. Randhawa P,. Role of donor kidney biopsies in renal transplantation. Transplant 2001; 71: 1361-1365.
16. Sung RS, Christensen LL, Leichtman AB, et al. Determinants of discard of expanded criteria donor kidneys: Impact of biopsy and machine perfusion. Am J Transplant 2008; 8: 783-792.
17. Mengel M, Sis B,. An appeal for zero-time biopsies in renal transplantation. Am J Transplant 2008; 11: 2181-2182.
18. Edwards EB, Posner MP, Maluf DG, Kauffman HM,. Reasons for non-use of recovered kidneys: the effect of donor glomerulosclerosis and creatinine clearance on graft survival. Transplant 2004; 77: 1411-1415.
19. Gaber LW, Moore LW, Alloway RR, Amiri MH, Vera SR, Gaber AO,. Glomerulosclerosis as a determinant of posttransplant function of older donor renal allografts. Transplant 1999; 60: 334-339.
20. Mueller TF, Solez K, Mas V,. Assessment of kidney organ quality and prediction of outcome at time of transplantation. Semin Immunopathol 2011; 33: 185-199.
21. Frei U, Noeldeke J, Machold-Fabrizii V, et al. Prospective age-matching in elderly kidney transplant recipients-a 5-year analysis of the Eurotransplant Senior Program. Am J Transplant 2008; 8: 50-57.
22. Cecka JM, Gritsch HA,. Why are nearly half of expanded criteria donor (ECD) kidneys not transplanted? Am J Transplant 2008; 8: 735-736.
23. Kurian SM, Flechner SM, Kaouk P, et al. Laparoscopic donor nephrectomy gene expression profiling reveals upregulation of stress and ischemia associated genes compared to control kidneys. Transplant 2005; 80: 1067-1071.
24. Hauser P, Schwarz C, Mitterbauer C, et al. Genome-wide gene-expression patterns of donor kidney biopsies distinguish primary allograft function. Lab Invest 2004; 84: 353-361.
25. Famulski KS, de Freitas DG, Kreepala C, et al. Molecular phenotypes of acute kidney injury in human kidney transplants. JASN 2012; 23: 948-958.
26. Sis B, Mengel M, Haas M, et al. Banff '09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464-471.
27. Remuzzi G, Grinyo J, Ruggenenti P, et al. Early experience with dual kidney transplantation in adults using expanded donor criteria. JASN 1999; 10: 2591-2598.
28. Remuzzi G, Cravedi P, Perna A, et al. Long-term outcome of renal transplantation from older donors. N Engl J Med 2006; 354: 343-352.
29. Munivenkatappa RB, Schweitzer EJ, Papadimitriou JC, et al. The Maryland aggregate pathology index: A deceased donor kidney biopsy scoring system for predicting graft failure. Am J Transplant 2008; 8: 2316-2324.
30. Daly PJ, Power RE, Healy DA, Hickey DP, Fitzpatrick JM, Watson RW,. Delayed graft function: a dilemma in renal transplantation. BJU Int 2005; 96: 498-501.
31. Humar A, Payne WD, Sutherland DE, Matas AJ,. Clinical determinants of multiple acute rejection episodes in kidney transplant recipients. Transplant 2000; 69: 2357-2360.
32. Rodrigo E, Ruiz JC, Pinera C, et al. Creatinine reduction ratio on post-transplant day two as criterion in defining delayed graft function. Am J Transplant 2004; 4: 1163-1169.
33. Metzger RA, Delmonico FL, Feng S, Port FK, Wynn JJ, Merion RM,. Expanded criteria donors for kidney transplantation. Am J Transplant 2003; 3 (Suppl 4): 114-125.
34. Ishani A, Erturk S, Hertz MI, Matas AJ, Savik K, Rosenberg ME,. Predictors of renal function following lung or heart-lung transplantation. Kidney Int 2002; 61: 2228-2234.
35. Mueller TF, Einecke G, Reeve J, et al. Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant 2007; 7: 2712-2722.
36. Einecke G, Reeve J, Sis B, et al. A molecular classifier for predicting future graft loss in late kidney transplant biopsies. J Clin Invest 2010; 120: 1862-1872.
37. Famulski KS, Einecke G, Reeve J, et al. Changes in the transcriptome in allograft rejection: IFN-g induced transcripts in mouse kidney allografts. Am J Transplant 2006; 6: 1342-1354.
38. Einecke G, Broderick G, Sis B, Halloran PF,. Early loss of renal transcripts in kidney allografts: Relationship to the development of histologic lesions and alloimmune effector mechanisms. Am J Transplant 2007; 7: 1121-1130.
39. Hidalgo LG, Sellares J, Sis B, Mengel M, Chang J, Halloran PF,. Interpreting NK cell transcripts versus T cell transcripts in renal transplant biopsies. Am J Transplant 2012; 5: 1180-1191.
40. Famulski KS, Einecke G, Sis B, et al. Defining the canonical form of T-cell-mediated rejection in human kidney transplants. Am J Transplant 2010; 10: 810-820.
41. Harrell FE,. Regression modelling strategies with applications to linear models, logistic regression and survival analysis. New York: Springer; 2001.
42. Port FK, Bragg-Gresham JL, Metzger RA, et al. Donor characteristics associated with reduced graft survival: An approach to expanding the pool of kidney donors. Transplant 2002; 74: 1281-1286.
43. Luyckx VA, Cairo LV, Compston CA, Phan WL, Mueller TF,. Oncostatin M pathway plays a major role in the renal acute phase response. Am J Physiol Renal Physiol 2009; 296: F875-F883.
44. Korbely R, Wilflingseder J, Perco P, et al. Molecular biomarker candidates of acute kidney injury in zero-hour renal transplant needle biopsies. Transpl Int 2011; 24: 143-149.
45. Avihingsanon Y, Ma N, Pavlakis M, et al. On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes. J Am Soc Nephrol 2005; 16: 1542-1548.
46. Siew ED, Ware LB, Ikizler TA,. Biological markers of acute kidney injury. J Am Soc Nephrol 2011; 22 (5): 810-820.
47. Naesens M, Li L, Ying LH, et al. Expression of complement components differs between kidney allografts from living and deceased donors. JASN 2009; 20: 1839-1851.
48. Mas VR, Scian MJ, Archer KJ, et al. Pretransplant transcriptome profiles identify among kidneys with delayed graft function those with poorer quality and outcome. Mol Med 2011; 17: 1311-1322.
49. Tullai JW, Schaffer ME, Mullenbrock S, Sholder G, Kasif S, Cooper GM,. Immediate-early and delayed primary response genes are distinct in function and genomic architecture. J Biol Chem 2007; 282: 23981-23995.
50. Tullai JW, Graham JR, Cooper GM,. A GSK-3-mediated transcriptional network maintains repression of immediate early genes in quiescent cells. Cell Cycle 2011; 10: 3072-3077.
51. Bajwa M, Cho YW, Pham PT, et al. Donor biopsy and kidney transplant outcomes: An analysis using the Organ Procurement and Transplantation Network/United Network for Organ Sharing (OPTN/UNOS) database. Transplant 2007; 84: 1399-1405.
52. Sellares J, De Freitas D, Mengel M, et al. Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and non-adherence. Am J Transplant 2012; 12: 388-399.